LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Crystalgenomics Inc.
Headquarters:
Seongnam, South Korea
Website:
http://www.crystalgenomics.com...
Year Founded:
2000
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Joong-Myung Cho, PhD
Number Of Employees:
N/A
Enterprise Value:
N/A
PE Ratio:
-3.61
Exchange/Ticker 1:
KOSDAQ:083790
Exchange/Ticker 2:
N/A
Latest Market Cap:
$124,173,760
BioCentury
|
May 26, 2021
Product Development
Korea Spotlight: Shaking off BI setback, Bridge expands scope of BD, advances in-house therapies
James Lee-led biotech has honed its focus and begun seeking deals as far off as Europe
Read More
BioCentury
|
Nov 21, 2016
Strategy
LG’s biotech legacy
How LG's shifting focus helped spawn a new biotech industry in South Korea
Read More
BioCentury
|
Jun 13, 2016
Company News
CrystalGenomics, Aptose Biosciences deal
Read More
BioCentury
|
Jun 9, 2016
Company News
Aptose, CrystalGenomics in deal for multi-kinase inhibitor
Read More
BioCentury
|
Mar 21, 2016
Product Development
Korea rising
How the Korean biopharma landscape is evolving
Read More
BioCentury
|
Feb 16, 2015
Clinical News
Acelex polmacoxib regulatory update
Read More
BioCentury
|
Feb 16, 2015
Company News
CrystalGenomics, Daewoong Pharmaceutical deal
Read More
BioCentury
|
Sep 15, 2014
Clinical News
CrystalGenomics preclinical data
Read More
BioCentury
|
Jun 30, 2014
Financial News
CrystalGenomics financial update
Read More
BioCentury
|
Jun 30, 2014
Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
Read More
Items per page:
10
1 - 10 of 35